Cardinal, McKesson, and Cencora have been busy during the past two years. These three drug distributors have spent over $17 billion acquiring large specialty medical groups from private equity sellers. Close review of the target acquisitions reveals a compelling business strategy involving in-office drug infusions, injections, and dispensing. Learn more at: https://datarise.cokergroup.com/blog/2025/08/27/17-billion-in-doctor-deals-done-by-drug-distributors/